Analysts' Actions -- Groupon, Humana, Monster, Merck and More
RATINGS CHANGES
Antero (AR) - Get Report was upgraded to hold from underperform at Jefferies. $27 price target. Management has addressed key concerns, Jefferies said.
Groupon (GRPN) - Get Report was upgraded to overweight from neutral at Piper Jaffray. $6 price target. Customer ramp should outperform expectations, Piper said.
Humana (HUM) - Get Report was upgraded to buy at Jefferies. $210 price target. The risk/reward is attractive, even if the Aetna deal breaks, Jefferies said.
Monster Beverage (MNST) - Get Report was downgraded to market perform from outperform at Wells Fargo. The company has limited earnings upside potential, Wells said.
Merck (MRK) - Get Report was downgraded to market perform from outperform at BMO Capital. The valuation is less attractive, based on a $62 price target, BMO said.
PacWest (PACW) - Get Report was downgraded to neutral at DA Davidson. The valuation is less attractive, based on a $45 price target, Davidson said.
Party City (PRTY) - Get Report was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: PRTY.
Parexel (PRXL) was downgraded to market perform from outperform at William Blair. The surprise CFO departure is concerning on multiple fronts, William Blair said.
QEP (QEP) - Get Report was upgraded to outperform at BMO Capital. The valuation is more attractive, based on a $24 price target, BMO said.
Regal (RGC) was downgraded to sector perform from outperform at RBC Capital. $23 price target. The valuation is less attractive, with shares up 15% over the past month, RBC said.
Total SA (TOT) - Get Report was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: TOT.
This article was written by a staff member of TheStreet.